Answer
Shkreli, known for his controversial pharmaceutical practices, faced legal consequences beyond the realm of healthcare. In a separate case, he was found guilty of securities fraud, specifically for misleading investors and engaging in fraudulent activities related to his former hedge funds, MSMB Capital Management and MSMB Healthcare. This conviction highlighted Shkreli's involvement in financial wrongdoings unrelated to his pharmaceutical endeavors.